首页> 外文期刊>Journal of comparative effectiveness research >Impact of an oral anticoagulation self-monitoring and self-management program in patients with mechanical heart valve prosthesis
【24h】

Impact of an oral anticoagulation self-monitoring and self-management program in patients with mechanical heart valve prosthesis

机译:口服抗凝自监测和自我管理方案对机械心阀假体患者的影响

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective: To analyze impact of implementation of an oral anticoagulation self-monitoring and self-management program among patients with mechanical valve prosthesis. Materials & methods: Observational and retrospective study performed in Hospital Moises Broggi, Barcelona, Spain. The program started on June 2019. The study compared 6-month period before and after the implementation of the program. Results: The study included 44 patients. There was a numerical increase of time in therapeutic range from 53.6 +/- 21.3% to 57.1 +/- 15.7% (p = 0.30). Proportion of patients with international normalized ratio (INR) >5 significantly decreased from 3.9 to 2.0% (p = 0.04). No significant differences were observed in thromboembolic or bleeding complications. Visits to emergency department decreased from (29.5 to 22.7%; p = 0.41). Conclusion: Oral anticoagulation self-monitoring and self-management program seems an appropriate approach that could provide additional benefits in selected patients with mechanical valve prosthesis.
机译:目的:分析在机械瓣膜假体患者中实施口服抗凝自我监测和自我管理计划的影响。材料与方法:在西班牙巴塞罗那莫伊斯·布罗吉医院进行的观察性和回顾性研究。该项目于2019年6月启动。该研究比较了该计划实施前后6个月的时间。结果:该研究包括44名患者。治疗范围内的时间从53.6+/-21.3%增加到57.1+/-15.7%(p=0.30)。国际标准化比值(INR)>5的患者比例从3.9%显著下降至2.0%(p=0.04)。血栓栓塞或出血并发症无显著差异。急诊科就诊人数从(29.5%降至22.7%;p=0.41)。结论:口服抗凝自我监测和自我管理计划似乎是一种合适的方法,可以为选择的机械瓣膜假体患者提供额外的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号